Nucleus RadioPharma

The Nucleus RadioPharma team is on the move and has tackled over 965 miles for the 3rd Edition Tackle Cancer Challenge with the Oncidium foundation! 🚴♂️ Do you want to join the movement to raise awareness for #radiotheranostics and funds that will be allocated exclusively to cancer patient projects? It is not too late to register! Sign up before the Challenge ends on November 10th: https://hubs.ly/Q02Wc-DV0 #Radiopharmaceuticals #CancerCare #RLT

When our two new facilities in Mesa, Arizona and Springhouse, Pennsylvania are operational, they’ll help us supply partners in Asia and Europe. Additionally, they will help us reduce the supply chain time for life-saving #radiopharmaceuticals by up to 30%. Special thanks to Anna Brown of Endpoints News for getting the word out on this exciting news. Hiring for the facilities will begin in late 2025. Stay tuned for updates! https://hubs.ly/Q02VKf7G0 #NuclearMedicine #CDMO #RLT

We’ve arrived in Hamburg, Germany! 🌍 Kathy Spencer-Pike, Chad Crookshanks, Shereen Gerrasch, and more are thrilled to be at the 37th Congress of the European Association of Nuclear Medicine (EANM). Our team is having such an informative experience exploring the latest advancements in #radiopharmaceuticals and #theranostics and connecting with the brightest minds in nuclear medicine. If you’re here, email BD@nucleusrad.com to set up a meeting time. #EANM24 #CDMO #RLT

Our mission is to improve access to life-saving theranostic #radiopharmaceuticals for the millions of patients who need them. To that end, we’re proud to announce one of the biggest steps we’ve taken to date: the development of two new facilities in Mesa, Arizona and Springhouse, Pennsylvania. Totaling more than 100,000 square feet, these new spaces for research, development, and commercial production were chosen for their proximity to important markets. They will help contribute to local economic growth in both areas and will allow partners like Fox Chase Cancer Center and Mayo Clinic to share in the benefits of scale and location. Check out all the details at the link below: https://hubs.ly/Q02Vbny30 #NuclearMedicine #CDMO #RLT

Interested in partnering with Nucleus RadioPharma for your #radiopharmaceutical CDMO needs? Whether you're biotech or pharma, partnering with the right CDMO is critical to success. In the latest edition of Nucleus Nexus, we break down four must-ask questions before entering into a partnership. Nucleus is committed to bringing your therapies to market quickly and safely. Email BD@nucleusrad.com to get started on your journey with us. #CDMO #RLT #Theranostics

The Nucleus RadioPharma team has jetted off and is on the way to European Association of Nuclear Medicine (EANM)'s Annual Congress! ✈ Are you also attending? Message BD@nucleusrad.com to schedule a time to learn more about Nucleus' comprehensive #radiopharmaceutical CDMO services and to talk about hot topics in the nuclear medicine field. #EANM24 #CDMO #Biotech #Theranostics

We can’t wait for tomorrow! The Tackle Cancer Challenge is about to begin, and all participants can start logging their kilometers in the app to help us reach our goal of 50,000 km together! Now more than ever, JOIN US 👉 https://buff.ly/3o2EI9B We have a SPECIAL INVITATION for all #EANM2024 participants 🤩: Join us for the official Tackle Cancer Challenge launch with a Run or Walk! Choose between 2 km and 5 km routes. 📆 October 18th at 6 PM 🚩 Planten & Bloemen Park, right next to the Congress Center Hamburg, Germany Who’s in? 🙌 #TCChallenge2024 European Association of Nuclear Medicine (EANM) Nucleus RadioPharma, BWXT Medical Telix Pharmaceuticals Limited IBA Perspective Therapeutics Nusano Evergreen Theragnostics, Isotopia Molecular Imaging ltd Tema Sinergie Laboratorios Bacon SHINE Technologies Nuclear Medicine Europe Comecer Lemer Pax. #TackleCancerChallenge #Oncidiumfoundation

⭐🔦 Employee Spotlight Series🔦⭐ Meet Dominic Siewko, Vice President of Radiation Safety and Environmental, Health & Safety (EHS) at Nucleus RadioPharma! 💊 Dominic’s passion for nuclear medicine started early in his career at a major teaching hospital in Boston where he was involved in radiation oncology and radiotherapies, including therapies like I-131 thyroid ablation. “The personal connections I made with patients, and seeing their appreciation for the care they received, made a big impact on my decision to pursue this field. At Nucleus RadioPharma, we’re on the cutting edge of manufacturing life-saving drugs at scale—helping real people with cancer, which is why I joined the team.” 🌍 As for the future? Dominic is focused on #theranostics and sees opportunities to make these innovative treatments more accessible. “Theranostics have a different workflow than traditional diagnostic procedures, and I see real opportunities to make these treatments more accessible in rural areas and simpler for healthcare providers to work with.” 💡 Career advice? Be open to challenges outside your comfort zone. “I once declined a role outside of my scope, but later realized it was an opportunity to grow. It taught me to be open to new areas of business. There is always room to grow.” We’re thrilled to have Dominic leading the charge in radiation safety and EHS and pushing the boundaries of innovation in #radiopharmaceuticals! #OurNucleus #EmployeeSpotlight #RadiationSafety #EHS

Nucleus RadioPharma's Chief Commercial Officer, Kathy Spencer-Pike, sat down with PharmaSource to discuss the current market and future for radiopharmaceuticals. Check out the article below to learn more about how these promising therapies require complex quality and safety standards. At Nucleus RadioPharma, we are committed to these standards and expanding our #CDMO services to ensure patients all over receive access to these treatments on time. #NuclearMedicine #Radiopharmaceuticals #CancerCare

As Nucleus RadioPharma continues to expand our capabilities as an end-to-end #radiopharmaceutical CDMO, the team at our Rochester, MN facility will be instrumental in our clients’ successes. Learn how Jennifer Vogel, our Production Manager, is driving crucial efforts to streamline radiopharmaceutical manufacturing processes while managing a world-class team.💡 https://hubs.ly/Q02S_2BG0 #NuclearMedicine #CDMO #RLT